Literature DB >> 23587319

Purification of infective baculoviruses by monoliths.

Petra Gerster1, Eva-Maria Kopecky, Nikolaus Hammerschmidt, Miriam Klausberger, Florian Krammer, Reingard Grabherr, Christa Mersich, Lidija Urbas, Petra Kramberger, Tina Paril, Matthias Schreiner, Katharina Nöbauer, Ebrahim Razzazi-Fazeli, Alois Jungbauer.   

Abstract

A chromatographic process based on monoliths for purification of infective baculovirus without prior concentration step has been established. Baculovirus produced in Spodoptera frugiperda cells (Sf-9) were harvested by centrifugation, filtered through 0.8 μm filters and directly loaded onto radial 1 mL anion exchange monoliths with a channel size of 1.5-2.0 μm operated at a volumetric flow rate of one bed volume per minute. Optional an epoxy monolith was used as pre-column to reduce interfering compounds and substances influencing the capacity of anion exchange monoliths for baculovirus infectious virus could be eluted with a step gradient at salt concentrations of 440 mM NaCl. Recovery of infectious virus was highly influenced by composition and age of supernatant and ranged from 20 to >99% active baculovirus. Total protein content could be reduced to 1-8% and DNA content to 38-48% in main virus fraction. Infective virus could be 52-fold concentrated within 20.5h and simultaneously an 82-fold volume reduction was possible when loading 1150 mL (2.1×10(8) pfu/mL) onto 1 mL scale support.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587319     DOI: 10.1016/j.chroma.2013.03.047

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  8 in total

Review 1.  Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages.

Authors:  Petra Kramberger; Lidija Urbas; Aleš Štrancar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography.

Authors:  Elad Lerer; Ziv Oren; Yaron Kafri; Yaakov Adar; Einat Toister; Lilach Cherry; Edith Lupu; Arik Monash; Rona Levy; Eyal Dor; Eyal Epstein; Lilach Levin; Meni Girshengorn; Niva Natan; Ran Zichel; Arik Makovitzki
Journal:  BioTech (Basel)       Date:  2021-10-12

Review 3.  Manufacturing of AcMNPV baculovirus vectors to enable gene therapy trials.

Authors:  Timothy Weixin Kwang; Xinhui Zeng; Shu Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2016-01-27       Impact factor: 6.698

Review 4.  Methacrylate Polymer Monoliths for Separation Applications.

Authors:  Robert J Groarke; Dermot Brabazon
Journal:  Materials (Basel)       Date:  2016-06-03       Impact factor: 3.623

5.  Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model.

Authors:  Kunitaka Yoshida; Mitsuhiro Iyori; Andrew M Blagborough; Ahmed M Salman; Pawan Dulal; Katarzyna A Sala; Daisuke S Yamamoto; Shahid M Khan; Chris J Janse; Sumi Biswas; Tatsuya Yoshii; Yenni Yusuf; Masaharu Tokoro; Adrian V S Hill; Shigeto Yoshida
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

6.  Monolith affinity chromatography for the rapid quantification of a single-chain variable fragment immunotoxin.

Authors:  Peter Satzer; Ralf Sommer; Johanna Paulsson; Agnes Rodler; Romana Zehetner; Klaus Hofstädter; Christoph Klade; Alois Jungbauer
Journal:  J Sep Sci       Date:  2018-07-01       Impact factor: 3.645

7.  At-line multi-angle light scattering detector for faster process development in enveloped virus-like particle purification.

Authors:  Patricia Pereira Aguilar; Irene González-Domínguez; Tobias Amadeus Schneider; Francesc Gòdia; Laura Cervera; Alois Jungbauer
Journal:  J Sep Sci       Date:  2019-06-19       Impact factor: 3.614

Review 8.  Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance.

Authors:  Guy-Alain Junter; Laurent Lebrun
Journal:  J Pharm Anal       Date:  2020-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.